Labshake search
Citations for R&D Systems :
1 - 50 of 90 citations for MT ND2 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Systems Biology 2022Quote: ... TNFɑ (R&D Systems, 410-MT) was diluted to a 100 ng/mL stock solution in PBS with 0.1% BSA ...
-
bioRxiv - Cell Biology 2023Quote: ... TNFα (R&D Systems: #410-MT), IL-1α (Abcam ...
-
bioRxiv - Cell Biology 2021Quote: ... mouse TNFα (410-MT, R&D Systems) and mouse IL6 (406-ML ...
-
bioRxiv - Neuroscience 2023Quote: ... and TNF (R&D Systems, 410-MT), which were added at 10ng/mL ...
-
bioRxiv - Immunology 2023Quote: ... and TNF (R&D Systems, #410-MT-010) serial 1:2 standard dilutions were added and plates were incubated overnight at 4°C ...
-
bioRxiv - Immunology 2023Quote: ... and TNF (R&D Systems, #410-MT-010) standards in 1:2 dilutions were added and plates were incubated overnight at 4°C ...
-
bioRxiv - Immunology 2023Quote: ... (410-MT-010/C, R&D Systems, USA)] to simulate a sterile inflammatory challenge ...
-
bioRxiv - Bioengineering 2022Quote: ... 0-10 nM for hMET-Fc (8614-MT-100, R&D Systems), 10 μg/mL for Ni-NTA coated donor beads and protein A-conjugated acceptor beads ...
-
Suppression of the Integrated Stress Response in Islet β Cells Decreases Risk of Autoimmune DiabetesbioRxiv - Cell Biology 2023Quote: ... 50 ng/mL mouse TNF-α (R&D Systems; 410-MT-010), and 100 ng/mL mouse IFN-γ (R&D Systems ...
-
bioRxiv - Developmental Biology 2022Quote: ... Luminal epithelial cells were treated with TNFα (410-MT-010, R&D systems) in DMEM/F12 with 2% charcoal-treated FBS (cFBS ...
-
bioRxiv - Cell Biology 2023Quote: ... cells were treated with 10 ng/mL TNFα (R&D Systems: #410-MT) for up to 10 h followed by the isolation of RNA and protein for qPCR and immunoblot ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50ng/ml tumor necrosis factor α (TNFα, R&D Systems #410-MT-025).
-
bioRxiv - Cell Biology 2024Quote: ... or 150 μg/kg TNF (R&D Systems Cat#410-MT/CF Lot CS152103) in DPBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... New media (with or without 10ng/mL recombinant TNF-α (R&D Systems 410-MT) was added ...
-
bioRxiv - Immunology 2024Quote: ... and 50 ng/mL TNF (R&D Systems, #410-MT-010, 100 µg/mL stock in PBS) diluted in PBS or PBS ...
-
bioRxiv - Immunology 2024Quote: ... and 50 ng/mL TNF (R&D Systems, #410-MT-010, 100 µg/mL stock in PBS) diluted in DMEM (Thermo Fisher Scientific ...
-
bioRxiv - Immunology 2024Quote: ... and 50 ng/mL TNF (R&D Systems, #410-MT-010, 100 µg/mL stock in PBS) diluted in DMEM (Thermo Fisher Scientific ...
-
bioRxiv - Bioengineering 2020Quote: ... a mix of recombinant mouse cytokines: 10 ng mL−1 TNF-α (R&D Systems # 410-MT-010), 10 ng mL−1 IL-1α (R&D Systems # 400-ML-005) ...
-
bioRxiv - Developmental Biology 2022Quote: ... with blastocyst size were incubated with TNFα (0.1% BSA/PBS (410-MT-010, R&D systems, Minnesota, USA) 37°C for 4 h ...
-
bioRxiv - Immunology 2019Quote: ... blocking anti-CXCR4 MAB21651 (247506, R&D Systems) or anti-CCR7 MAB3477 (4B12 ...
-
bioRxiv - Cell Biology 2022Quote: ... TNF-α treatment was done by treating BMDMs with 100ng/ml TNF-α (410-MT-010, R&D Systems).
-
bioRxiv - Cell Biology 2022Quote: ... αCCR7 blocking antibody (R&D systems, 2-5μg/ml), rat immunoglobulin (Ig ...
-
bioRxiv - Neuroscience 2022Quote: ... Anti-Nrp2 function blocking antibody (AF2215, R&D Systems) was applied at a concentration of 10 µg/mL ...
-
bioRxiv - Physiology 2020Quote: ... PD-1 blocking antibody (R&D Systems/Techne, #AF1086) was included at the 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... blocked with Mouse on Mouse Blocking Reagent (R&D Systems) 2h and incubated with primary antibody ...
-
bioRxiv - Immunology 2022Quote: ... after blocking with Reagent Diluent (R&D System, ref DY006), 100-μL standard dilutions and samples were added to each well and incubated 2 hours at RT ...
-
bioRxiv - Biochemistry 2020Quote: ... Fluorogenic peptide substrates were obtained from R&D systems, where Mca-YVADAPK(Dnp)-OH (ES007 ...
-
bioRxiv - Neuroscience 2021Quote: ... + β-heregulin peptide (R&D Systems, Cat# 396-HB-050) + forskolin (Cayman Chemical ...
-
bioRxiv - Cancer Biology 2019Quote: ... respectively) and recombinant proteins used for quantification (8614-MT, 344-ER, 1129-ER, and 348-RB respectively) were from R&D systems. Streptavidin Phycoerythrin (SAPE ...
-
bioRxiv - Neuroscience 2022Quote: ... 506-RL-010/CF) and carrier free Recombinant Mouse TNF-alpha (aa 80-235) Protein (410-MT-025/CF) purchased from R&D Systems.
-
bioRxiv - Cell Biology 2019Quote: ... a fluorogenic peptide substrate of MMPs (R&D systems, USA). The fluorgenic substrate (5 μM ...
-
bioRxiv - Neuroscience 2024Quote: ... recombinant control peptide (R&D systems, cat. #4460, Accession # P01863) is mouse melanoma cell line ...
-
bioRxiv - Systems Biology 2020Quote: ... mouse anti-IL-10R blocking antibody (10 µg/mL, R&D Systems) or mouse anti-TNFα Receptors 1 and 2 (10 µg/mL ...
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Synthetic Biology 2024Quote: ... 10% BSA ELISA reagent diluent/blocking solution concentrate (DY995, R&D systems) and TMB substrate (421501 ...
-
bioRxiv - Cancer Biology 2019Quote: ... and CXCR4 antagonist peptide AMD3100 were procured from R&D systems. All chemicals and antibodies were obtained from Sigma unless specified otherwise.
-
bioRxiv - Neuroscience 2022Quote: ... 10µg/ml of a VEGF function-blocking antibody (R&D Systems MAB9947-SP) was added to differentiation media and 10µg/ml of control IgG (Biolegend 403501 ...
-
bioRxiv - Bioengineering 2023Quote: ... and a TGFβ blocking antibody (20 µg mL-1, #MAB1835, R&D Systems). Trastuzumab (#MAB9589 ...
-
bioRxiv - Immunology 2023Quote: ... 30 µg/ml of anti-LOX-1 blocking antibody (polyclonal, R&D Systems) or goat IgG isotype (Biolegend ...
-
bioRxiv - Immunology 2023Quote: ... using either PCSK9 peptides or recombinant mPCSK9/hPCSK9 protein (R&D Systems) as the coating antigen ...
-
bioRxiv - Cell Biology 2024Quote: ... co-housed 8-week-old female C57BL/6J wildtype mice were administered either 300 μg/kg TNF (R&D Systems Cat#410-MT/CF Lot CS152103) in endotoxin-free DPBS or endotoxin-free DPBS alone (Merck Cat# TMS-012-A ...
-
bioRxiv - Immunology 2021Quote: ... Blocking of ACE2 was performed with 8 ug/mL anti-ACE2 (R&D systems) for 30 min at 37°C before adding stimuli ...
-
bioRxiv - Cancer Biology 2019Quote: ... Each well was supplemented with PDGFR-α blocking antibody (1:100; R&D Systems), or Imatinib (Seleckchem) ...
-
bioRxiv - Neuroscience 2021Quote: ... and incubated for 1 hour with blocking buffer (Reagent Diluent, R&D Systems, UK). Plates were washed 3 times with wash buffer and 100 ul of samples and standards were added (R&D Systems ...
-
bioRxiv - Systems Biology 2022Quote: ... avidin and biotin blocking reagents (HRP-DAB Cell &Tissue Staining Kit, R&D Systems) and washing in TBST in between each blocking step ...
-
bioRxiv - Neuroscience 2023Quote: cleaved caspase 3 (Cat. No. MAB835, 1:200 in blocking solution, R&D Systems), dsDNA (Cat No ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with RGDS peptide (10 μg/mL, R&D systems, MN, USA) (20 ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... incubated with the fluorogenic peptide substrate Z-FR-AMC (150 μM; R&D Systems) and measured at a fluorometer following a 0 to 30 min incubation (ƛEx = 390 nm ...